CIRM Funded Clinical Trials
TACH101: A Potent, First-In-Class KDM4 Inhibitor for Advanced Cancers
Disease Area:
Colon Cancer
Trial Sponsor:
Tachyon Therapeutics, Inc
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A
ClinicalTrials.gov ID:
